CORAL Clinical Trial Overview:
Chronic Cough Reduction for Patients with IPF

Join us for this webinar as Dr. Émilie Millaire explains to us Trevi Therapeutic’s CORAL phase 2 clinical trial which aims to reduce chronic cough in patients with idiopathic pulmonary fibrosis (IPF).

Learn about previous trial results, how to participate in the upcoming CORAL trial, and what to expect.

Sign up for the webinar below.
Live stream will start at 7PM EDT on June 27, 2024.